Literature DB >> 21968650

The gene expression profile of phosphoantigen-specific human γδ T lymphocytes is a blend of αβ T-cell and NK-cell signatures.

Fréderic Pont1, Julien Familiades, Sébastien Déjean, Séverine Fruchon, Delphine Cendron, Mary Poupot, Rémy Poupot, Fatima L'faqihi-Olive, Nais Prade, Bernard Ycart, Jean-Jacques Fournié.   

Abstract

Global transcriptional technologies have revolutionised the study of lymphoid cell populations, but human γδ T lymphocytes specific for phosphoantigens remain far less deeply characterised by these methods despite the great therapeutic potential of these cells. Here we analyse the transcriptome of circulating TCRVγ(+) γδ T cells isolated from healthy individuals, and their relation with those from other lymphoid cell subsets. We report that the gene signature of phosphoantigen-specific TCRVγ(+) γδ T cells is a hybrid of those from αβ T and NK cells, with more 'NK-cell' genes than αβ T cells have and more 'T-cell' genes than NK cells. The expression profile of TCRVγ(+) γδ T cells stimulated with phosphoantigen recapitulates their immediate physiological functions: Th1 cytokine, chemokine and cytotoxic activities reflect their high mitotic activity at later time points and do not indicate antigen-presenting functions. Finally, such hallmarks make the transcriptome of γδ T cells, whether resting or clonally expanding, clearly distinctive from that of NK/T or peripheral T-cell lymphomas of the γδ subtype.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968650     DOI: 10.1002/eji.201141870

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Authors:  Marie Tosolini; Frédéric Pont; Mary Poupot; François Vergez; Marie-Laure Nicolau-Travers; David Vermijlen; Jean-Emmanuel Sarry; Francesco Dieli; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

2.  Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Authors:  Gabriele Pizzolato; Hannah Kaminski; Marie Tosolini; Don-Marc Franchini; Fréderic Pont; Fréderic Martins; Carine Valle; Delphine Labourdette; Sarah Cadot; Anne Quillet-Mary; Mary Poupot; Camille Laurent; Loic Ysebaert; Serena Meraviglia; Francesco Dieli; Pierre Merville; Pierre Milpied; Julie Déchanet-Merville; Jean-Jacques Fournié
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

3.  Human Vδ2 T cells are a major source of interleukin-9.

Authors:  Christian Peters; Robert Häsler; Daniela Wesch; Dieter Kabelitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

4.  Human monocyte recognition of adenosine-based cyclic dinucleotides unveils the A2a Gαs protein-coupled receptor tonic inhibition of mitochondrially induced cell death.

Authors:  Marie Tosolini; Frédéric Pont; Delphine Bétous; Emmanuel Ravet; Laetitia Ligat; Frédéric Lopez; Mary Poupot; Marc Poirot; Éric Pérouzel; Gérard Tiraby; Els Verhoeyen; Jean-Jacques Fournié
Journal:  Mol Cell Biol       Date:  2014-11-10       Impact factor: 4.272

Review 5.  γδ T cell therapy for the treatment of non-small cell lung cancer.

Authors:  Kazuhiro Kakimi; Hirokazu Matsushita; Tomohiro Murakawa; Jun Nakajima
Journal:  Transl Lung Cancer Res       Date:  2014-02

6.  Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.

Authors:  Tanya Dimova; Margreet Brouwer; Françoise Gosselin; Joël Tassignon; Oberdan Leo; Catherine Donner; Arnaud Marchant; David Vermijlen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-23       Impact factor: 11.205

Review 7.  What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Authors:  Jean-Jacques Fournié; Hélène Sicard; Mary Poupot; Christine Bezombes; Amandine Blanc; François Romagné; Loic Ysebaert; Guy Laurent
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

8.  Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.

Authors:  Maria Themeli; Christopher C Kloss; Giovanni Ciriello; Victor D Fedorov; Fabiana Perna; Mithat Gonen; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2013-08-11       Impact factor: 54.908

9.  Molecular definition of the identity and activation of natural killer cells.

Authors:  Natalie A Bezman; Charles C Kim; Joseph C Sun; Gundula Min-Oo; Deborah W Hendricks; Yosuke Kamimura; J Adam Best; Ananda W Goldrath; Lewis L Lanier
Journal:  Nat Immunol       Date:  2012-08-19       Impact factor: 25.606

10.  Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors.

Authors:  Daniel V Correia; António Lopes; Bruno Silva-Santos
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.